<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366678">
  <stage>Registered</stage>
  <submitdate>8/07/2014</submitdate>
  <approvaldate>30/07/2014</approvaldate>
  <actrnumber>ACTRN12614000808640</actrnumber>
  <trial_identification>
    <studytitle>Can treatment of  unexplained recurrent abortion patients with nitric oxide donors decrease the incidence of abortion?</studytitle>
    <scientifictitle>Comparative study between folic acid control group and folic acid plus isosorbid mononitrate as a nitric oxide donors study group treatment of unexplained recurrent abortion  patients as regards incidence of abortion </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Unexplained recurrent abortion</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fertility including in vitro fertilisation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A control of 30 patients with unexplained recurrent abortion treated with folic acid 0.5 mg once daily orally starting before pregnancy until 20 weeks gestation and a study group of 30 patients treated with folic acid 0.5 mg once daily orally plus isosorbid mononitrate 20 mg dailly applied vaginally </interventions>
    <comparator>Control group treated with folic acid 0.5 mg orally from before pregnancy to 20 weeks gestation</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Incidence of abortion in both groups</outcome>
      <timepoint>20 weeks gestation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Uterine artery resistance and pulsation indices before treatment and at 20 weeks gestation after treatment measured by trans-vaginal and trans-abdominal pulsed color Doppler ultrasound  </outcome>
      <timepoint>20 weeks gestation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with unexplained recurrent abortion with normal uterine cavity, normal glucose tolerance, normal levels of antiphospholipid antibodies, normal thyroid functions and normal karyotyping  </inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>30</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients treated with vasodilators</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2013</anticipatedstartdate>
    <actualstartdate>1/01/2013</actualstartdate>
    <anticipatedenddate>1/12/2013</anticipatedenddate>
    <actualenddate>1/12/2013</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Benha university hospital</primarysponsorname>
    <primarysponsoraddress>Kalyoupia , Benha, Farid Nada street</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Benha university hospital</fundingname>
      <fundingaddress>Kalyuopia, Benha, Farid Nada street, 

</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study included a control and a study group each 30 cases with history of unexplained recurrent abortion. The control group was treated with folic acid tablet 0.5 mg once daily orally and the study group treated with folic acid plus isosorbid mononitrate 20 mg given vaginally. Treatment was given monthly from day 21-23 of the cycle until menstruation and continued if pregnancy occurred until 20 weeks gestation. Doppler ultrasound was done vaginally before treatment and abdominally at 20 weeks gestation to measure uterine artery resistance and pulsation indices. Patients were treated until 20 weeks gestation to compare uterine artery indices before and after treatment and the incidence of abortion in both groups </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Mohamed Abdelrazik</name>
      <address>Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha, Farid Nada street</address>
      <phone>+20    02 26070837  or +20  013  3225385</phone>
      <fax />
      <email>Prof.mohamedabdelrazik@hotmail.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Mohamed Abdelrazik</name>
      <address>Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha, Farid Nada street</address>
      <phone>+20    02 26070837  or +20  013  3225385</phone>
      <fax />
      <email>Prof.mohamedabdelrazik@hotmail.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Mohamed Abdelrazik</name>
      <address>Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha, Farid Nada street</address>
      <phone>+20    02 26070837  or +20  013  3225385</phone>
      <fax />
      <email>Prof.mohamedabdelrazik@hotmail.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>